Darzalex 400mg/20ml, Konzentrat zur Herstellung einer Infusionslösung
7680660720048
CH-66072
Konzentrat
Associated product:
DARZALEX conc perf 400 mg/20ml flac 20 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1093.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1767.05
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2017
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 66072
- Drug name
- Darzalex, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOPA
- ATC Code
- L01FC01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 06/12/2016
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- DARZALEX conc perf 400 mg/20ml flac 20 ml
- Description (DE)
- DARZALEX Inf Konz 400 mg/20ml Durchstf 20 ml
- Market launch
- 27/01/2023
- Narcotic (BTM)
- No
Other package sizes (3)
DARZALEX conc perf 100 mg/5ml (#) flac 5 ml
1 DUR
GTIN: 7680660720017
DARZALEX conc perf 400 mg/20ml (#) flac 20 ml
1 DUR
GTIN: 7680660720024
DARZALEX conc perf 100 mg/5ml flac 5 ml
1 DUR
GTIN: 7680660720031